Tender Notice for Tab Naproxen 250mg,Tab Tramadol HCl 50 mg,Tab Prednisolone 5 mg,Tab Carbamazepine 200 mg,Tab Clobaz

The eligibility requirements for participating in this tender include being a registered entity in the pharmaceutical domain, with an established history of compliance with health and safety regulations. Bidders must also demonstrate the financial capacity to manage a large-scale supply contract.

To participate in this tender, suppliers must provide certificates demonstrating compliance with quality assurance standards, relevant health and safety regulations, as well as any certifications specific to pharmaceutical supply and distribution.

Bidders interested in this tender must register on the GeM portal, completing all required forms and providing necessary documentation that demonstrates their capabilities, prior experience, and compliance with regulations.

All documents submitted must be in the specified formats outlined in the tender documentation. Typically, formats such as PDFs or Word documents are favored, but bidders should review the tender guidelines for precise requirements.

The technical specifications set forth by the issuing authority include compliance with recognized quality standards for pharmaceuticals, along with the capability to conduct specified testing on provided products if required.

Bidders are expected to meet all applicable quality standards as outlined in the official documentation. This often includes adhering to standards set forth by health regulatory authorities and internal standards of the Ministry of Defence.

Compliance requirements include adherence to pharmaceutical regulations, proof of licensing, quality certifications, as well as compliance with any specific guidelines outlined in the tender documents.

Bidders may be required to present a performance security bond, the details of which will be stipulated in the tender documentation. This performance security demonstrates a supplier's commitment to fulfilling contract terms.

Payment terms typically involve milestone payments, which may be contingent on successful delivery and acceptance of the products supplied as per the tender agreements.

Pricing will be evaluated based on competitiveness, with considerations for both overall cost and compliance with specified quality standards. Pricing proposals should reflect market rates while also ensuring sustainable profit margins for the supplier.

Though the specific dates are subject to change, bidders should refer to the official documentation for the latest information regarding timelines for submission, bid openings, and any requisite steps needed throughout the tender process.

The selection process will evaluate submissions based on both technical qualification and financial proposals. The evaluation committee will assess adherence to the requirements outlined, ensuring a balanced consideration of quality and cost.

MSEs may benefit from relaxed eligibility criteria and potential support mechanisms aimed at facilitating their participation in government tenders and procurement opportunities, thereby promoting inclusivity.

Startups may also find supportive provisions noted within the tender documentation that allow for greater participation flexibility and assistance in meeting regulatory and compliance requirements.

The procurement process under this tender encourages local production and aims to align with 'Make in India' initiatives by fostering opportunities for domestic suppliers and manufacturers within the pharmaceutical sector.

Local content rules mandate a certain percentage of local sourcing in product manufacturing, as directed under the guidelines of the Department of Military Affairs. Bidders must ensure their proposals adhere to these procurement rules.